Trudell Medical Group Makes a Strategic Investment in Xenocor, Developer of the Xenoscope

SALT LAKE CITY: SALT LAKE CITY, June 22, 2021 /PRNewswire/ -- Xenocor Inc. today announced a strategic investment by Barvest Ventures Inc., a member company of the Trudell Medical Group, which is a innovator and global leader in respiratory care and medical device development. This investment will enable Xenocor to...

Click to view original post